Symptoms and the 5 Clinical Signs of Trachoma
At a Glance
Trachoma may cause few symptoms at first, but repeated inflammation can scar the eyelid, turn lashes inward, and damage the cornea, the eye's clear front. A trained health worker should examine the turned-out upper eyelid; painful lashes or a cloudy cornea need prompt professional assessment.
Trachoma is tracked by health programs using five clinical signs defined by the World Health Organization (WHO) simplified grading system [1]. Understanding these signs is vital because the early phases often have very few symptoms, yet they set the foundation for future vision loss [2].
Health workers assess these signs by gently everting (turning inside out) the upper eyelid to inspect the conjunctiva, the pink lining on the underside of the lid [3].
Important Safety Warning: Do not attempt to force an eyelid open or diagnose these signs yourself at home. Conditions like allergies and other infections can also cause red eyes and bumps. Rely on a trained health worker to perform this exam safely.
The Active Signs: Often Seen in Childhood
The first two clinical signs are known as “active trachoma.” These represent the body’s immediate reaction to the bacteria [4]. Patients do not always progress neatly from one to the next; these signs can co-exist.
- TF: Trachomatous Inflammation—Follicular: A health worker will look for at least five follicles—small, pale, white or yellow bumps—on the inside of the upper eyelid [5].
- TI: Trachomatous Inflammation—Intense: In this presentation, the inflammation is more severe. The lining of the eyelid becomes thick, red, and swollen, often hiding the normal blood vessels underneath [1].
- What you may feel: The eye may feel irritated or painful. This sign is particularly concerning because intense inflammation is a strong predictor of future scarring [7].
The Scarring Signs: Late-Stage Damage
As a person grows older, repeated bouts of active infection lead to permanent changes in the eyelid. This “scarring phase” can continue even if the original infection has been treated [8].
- TS: Trachomatous Scarring: The follicles from the active phase heal and leave behind white lines or patches of scar tissue on the inside of the eyelid [9].
- TT: Trachomatous Trichiasis: This is a critical sign where the scarred eyelid has turned inward, causing the eyelashes to scratch the eyeball [11]. Note that while the official WHO program definition focuses on upper eyelid lashes for tracking purposes, any inward-turning eyelash on the upper or lower lid can damage the cornea and requires prompt assessment [1].
- CO: Corneal Opacity: The constant scratching from the eyelashes causes the cornea—the clear window of the eye—to develop dense, cloudy, or white patches [13].
Why Professional Screening is Essential
Because the transition from “bumps” (TF) to “scars” (TS) happens slowly over many years, you might not notice the damage until the painful stage of inward-turning lashes begins [8]. Regular eye checks by trained health workers are the only way to catch trachoma in its early, silent stages [14]. It is also important to remember that clinical signs like TF can sometimes persist for months even after the bacteria have been cleared by antibiotics, which is why health workers may continue to monitor or treat a community even if people feel healthy [15].
Common questions in this guide
What are the five clinical signs used to grade trachoma?
What does TF look or feel like?
Why is intense trachomatous inflammation concerning?
What does trichiasis feel like, and how urgently should it be checked?
Does a cloudy cornea always mean trachoma?
Can trachoma signs remain after antibiotic treatment?
How is trachoma checked safely?
Get notified when new evidence is published on trachoma.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (15)
- 1
The simplified trachoma grading system, amended.
Solomon AW, Kello AB, Bangert M, et al.
Bulletin of the World Health Organization 2020; (98(10)):698-705 doi:10.2471/BLT.19.248708.
PMID: 33177759 - 2
The Relationship between Active Trachoma and Ocular Chlamydia trachomatis Infection before and after Mass Antibiotic Treatment.
Ramadhani AM, Derrick T, Macleod D, et al.
PLoS neglected tropical diseases 2016; (10(10)):e0005080 doi:10.1371/journal.pntd.0005080.
PMID: 27783678 - 3
Inter-Rater Agreement between Trachoma Graders: Comparison of Grades Given in Field Conditions versus Grades from Photographic Review.
Gebresillasie S, Tadesse Z, Shiferaw A, et al.
Ophthalmic epidemiology 2015; (22(3)):162-9 doi:10.3109/09286586.2015.1035792.
PMID: 26158573 - 4
High prevalence of active trachoma and associated factors among school-aged children in Southwest Ethiopia.
Getachew D, Woldekidan F, Ayele G, et al.
PLoS neglected tropical diseases 2023; (17(12)):e0011846 doi:10.1371/journal.pntd.0011846.
PMID: 38100523 - 5
A diagnostic instrument to help field graders evaluate active trachoma.
Solomon AW, Le Mesurier RT, Williams WJ
Ophthalmic epidemiology 2018; (25(5-6)):399-402 doi:10.1080/09286586.2018.1500616.
PMID: 30067432 - 6
Multimodal mucosal and systemic immune characterization of a non-human primate trachoma model highlights the critical role of local immunity during acute phase disease.
Paulet E, Contreras V, Galhaut M, et al.
PLoS neglected tropical diseases 2024; (18(8)):e0012388 doi:10.1371/journal.pntd.0012388.
PMID: 39093884 - 7
Twenty-Three Population-Based Trachoma Prevalence Surveys in the Central and Northern Regions of Benin, 2018-2022.
Issifou AAB, Dare A, Badou GA, et al.
Ophthalmic epidemiology 2024; (31(6)):498-508 doi:10.1080/09286586.2023.2265796.
PMID: 38032921 - 8
Pathogenesis of progressive scarring trachoma in Ethiopia and Tanzania and its implications for disease control: two cohort studies.
Burton MJ, Rajak SN, Hu VH, et al.
PLoS neglected tropical diseases 2015; (9(5)):e0003763 doi:10.1371/journal.pntd.0003763.
PMID: 25970613 - 9
The population-based prevalence of trachomatous scarring in a trachoma hyperendemic setting: results from 152 impact surveys in Amhara, Ethiopia.
Astale T, Ebert CD, Nute AW, et al.
BMC ophthalmology 2021; (21(1)):213 doi:10.1186/s12886-021-01972-w.
PMID: 33985443 - 10
Blinding Trachoma: Systematic Review of Rates and Risk Factors for Progressive Disease.
Ramadhani AM, Derrick T, Holland MJ, Burton MJ
PLoS neglected tropical diseases 2016; (10(8)):e0004859 doi:10.1371/journal.pntd.0004859.
PMID: 27483002 - 11
Insights into Pathogenesis of Trachoma.
Toumasis P, Vrioni G, Tsinopoulos IT, et al.
Microorganisms 2024; (12(8)) doi:10.3390/microorganisms12081544.
PMID: 39203386 - 12
The Gambia Trachomatous Trichiasis Surveys: Results from Five Evaluation Units Confirm Attainment of Trachoma Elimination Thresholds.
Kanyi S, Hydara A, Sillah A, et al.
Ophthalmic epidemiology 2024; (31(6)):534-542 doi:10.1080/09286586.2023.2213320.
PMID: 37401113 - 13
- 14
The prevalence of trachoma, ocular Chlamydia trachomatis infection and anti-Pgp3 antibodies in Choiseul Province, Solomon Islands.
Dyer CEF, Cowling CS, Sokana O, et al.
PLoS neglected tropical diseases 2025; (19(9)):e0013381 doi:10.1371/journal.pntd.0013381.
PMID: 40920869 - 15
Pgp3 seroprevalence and associations with active trachoma and ocular Chlamydia trachomatis infection in Malawi: cross-sectional surveys in six evaluation units.
Burr SE, Hart J, Samikwa L, et al.
PLoS neglected tropical diseases 2019; (13(10)):e0007749 doi:10.1371/journal.pntd.0007749.
PMID: 31658258
This page is for informational purposes only and does not constitute medical advice. Do not evert an eyelid yourself; a trained health worker or eye professional should assess possible trachoma, inward-turning lashes, or corneal cloudiness.